{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:13:07Z","timestamp":1784157187110,"version":"3.55.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40257-017-0338-1","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T13:55:44Z","timestamp":1515074144000},"page":"377-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["A Review on Pityriasis Rubra Pilaris"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7563","authenticated-orcid":false,"given":"Dingyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Cui-Lian","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel H.","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"338_CR1","first-page":"648","volume":"2","author":"C Tarral","year":"1835","unstructured":"Tarral C. General psoriasis. Desquamation from the parts covered with hair. Theor Pract Treatise Dis Skin. 1835;2:648\u20139.","journal-title":"Theor Pract Treatise Dis Skin."},{"key":"338_CR2","first-page":"197","volume":"3","author":"MGA Devergie","year":"1856","unstructured":"Devergie MGA. Pityriasis pilaris, maladie de peau non decrite par les dermatologistes. Gaz Hebd Med Chir. 1856;3:197\u2013201.","journal-title":"Gaz Hebd Med Chir."},{"key":"338_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","volume":"5","author":"WA Griffiths","year":"1980","unstructured":"Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol. 1980;5:105\u201312.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2133.1989.tb08229.x","volume":"121","author":"VN Sehgal","year":"1989","unstructured":"Sehgal VN, Jain MK, Mathur RP. Pityriasis rubra pilaris in Indians. Br J Dermatol. 1989;121:821\u20132.","journal-title":"Br J Dermatol."},{"key":"338_CR5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1525-1470.1986.tb00648.x","volume":"3","author":"C Gelmetti","year":"1996","unstructured":"Gelmetti C, Schiuma AA, Cerri D, Gianotti F. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol. 1986;3:446\u201351.","journal-title":"Pediatr Dermatol."},{"key":"338_CR6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","volume":"133","author":"ES Miralles","year":"1995","unstructured":"Miralles ES, N\u00fa\u00f1ez M, De Las Heras ME, P\u00e9rez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol. 1995;133:990\u20133.","journal-title":"Br J Dermatol."},{"key":"338_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11530070-000000000-00000","volume":"11","author":"A Klein","year":"2010","unstructured":"Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010;11:157\u201370.","journal-title":"Am J Clin Dermatol."},{"key":"338_CR8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/1529-0131(199909)42:9<1998::AID-ANR28>3.0.CO;2-D","volume":"42","author":"PG Conaghan","year":"1999","unstructured":"Conaghan PG, Sommer S, McGonagle D, Veale D, Waldmann H, Hale G, et al. The relationship between pityriasis rubra pilaris and inflammatory arthritis: case report and response of the arthritis to anti-tumor necrosis factor immunotherapy. Arthritis Rheum. 1999;42:1998\u20132001.","journal-title":"Arthritis Rheum."},{"key":"338_CR9","volume-title":"Dermatology","author":"GS Wood","year":"2012","unstructured":"Wood GS, Reizner GT. Other papulosquamous disorders. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. Philadelphia: Elsevier Ltd (Saunders); 2012."},{"key":"338_CR10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.1999.02829.x","volume":"140","author":"A Gonz\u00e1lez-L\u00f3pez","year":"1999","unstructured":"Gonz\u00e1lez-L\u00f3pez A, Velasco E, Pozo T, Del Villar A. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol. 1999;140:931\u20134.","journal-title":"Br J Dermatol."},{"key":"338_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2133.1992.tb00111.x","volume":"126","author":"AG Martin","year":"1992","unstructured":"Martin AG, Weaver CC, Cockerell CJ, Berger TG. Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne. Br J Dermatol. 1992;126:617\u201320.","journal-title":"Br J Dermatol."},{"key":"338_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2230.2004.01571.x","volume":"29","author":"C Blasdale","year":"2004","unstructured":"Blasdale C, Turner RJ, Leonard N, Ong ELC, Lawrence CM. Spontaneous clinical improvement in HIV-associated follicular syndrome. Clin Exp Dermatol. 2004;29:480\u20132.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","volume":"91","author":"D Fuchs-Telem","year":"2012","unstructured":"Fuchs-Telem D, Sarig O, van Steensel MAM, Isakov O, Israeli S, Nousbeck J, et al. Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet. 2012;91:163\u201370.","journal-title":"Am J Hum Genet."},{"key":"338_CR14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archderm.1995.01690160076012","volume":"131","author":"SL Vanderhooft","year":"1995","unstructured":"Vanderhooft SL, Francis JS, Holbrook KA, Dale BA, Fleckman P. Familial pityriasis rubra pilaris. Arch Dermatol. 1995;131:448\u201353.","journal-title":"Arch Dermatol."},{"key":"338_CR15","first-page":"844","volume":"9","author":"M Vasher","year":"2010","unstructured":"Vasher M, Smithberger E, Lien MH, Fenske NA. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J Drugs Dermatol JDD. 2010;9:844\u201350.","journal-title":"J Drugs Dermatol JDD."},{"key":"338_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson EDO, Pierson KC, Yang C-F, Joyce CE, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90:784\u201395.","journal-title":"Am J Hum Genet."},{"key":"338_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamadermatol.2016.3601","volume":"153","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Sugiura K, Nomura T, Sakamoto T, Ogawa Y, Oiso N, et al. Pityriasis rubra pilaris type V as an autoinflammatory disease by CARD14 mutations. JAMA Dermatol. 2017;153:66\u201370.","journal-title":"JAMA Dermatol."},{"key":"338_CR18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/bjd.12799","volume":"170","author":"O Eytan","year":"2014","unstructured":"Eytan O, Qiaoli L, Nousbeck J, van Steensel MA, Burger B, Hohl D, et al. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris. Br J Dermatol. 2014;170:1196\u20138.","journal-title":"Br J Dermatol."},{"key":"338_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archinte.1931.00150030158012","volume":"48","author":"CN Frazier","year":"1931","unstructured":"Frazier CN, Ch\u2019uan-K\u2019uei H. Cutaneous lesions associated with a deficiency in vitamin A in man. Arch Intern Med. 1931;48:507\u201314.","journal-title":"Arch Intern Med."},{"key":"338_CR20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archderm.1936.01470110045005","volume":"33","author":"CN Frazier","year":"1936","unstructured":"Frazier CN, Ch\u2019uan-K\u2019uei H. Nature and distribution according to age of cutaneous manifestations of vitamin A deficiency: a study of two hundred and seven cases. Arch Dermatol Syphilol. 1936;33:825\u201352.","journal-title":"Arch Dermatol Syphilol."},{"key":"338_CR21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archderm.1933.01460050094008","volume":"28","author":"LJA Loewenthal","year":"1933","unstructured":"Loewenthal LJA. A new cutaneous manifestation in the syndrome of vitamin A deficiency. Arch Dermatol Syphilol. 1933;28:700\u20138.","journal-title":"Arch Dermatol Syphilol."},{"key":"338_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0190-9622(82)80258-2","volume":"7","author":"WA Griffiths","year":"1982","unstructured":"Griffiths WA. Vitamin A and pityriasis rubra pilaris. J Am Acad Dermatol. 1982;7:555.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archderm.1969.01610240068012","volume":"99","author":"DA Gross","year":"1969","unstructured":"Gross DA, Landau JW, Newcomer VD. Pityriasis rubra pilaris: report of a case and analysis of the literature. Arch Dermatol. 1969;99:710\u20136.","journal-title":"Arch Dermatol."},{"key":"338_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.1981.tb00946.x","volume":"104","author":"AF Finzi","year":"1981","unstructured":"Finzi AF, Altomare G, Bergamaschini L, Tucci A. Pityriasis rubra pilaris and retinol-binding protein. Br J Dermatol. 1981;104:253\u20136.","journal-title":"Br J Dermatol."},{"key":"338_CR25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2340\/0001555564430432","volume":"64","author":"PC Voorst Vader Van","year":"1984","unstructured":"Van Voorst Vader PC, Van Oostveen F, Houthoff HJ, Marrink J. Pityriasis rubra pilaris, vitamin A and retinol-binding protein: a case study. Acta Derm Venereol. 1984;64:430\u20132.","journal-title":"Acta Derm Venereol."},{"key":"338_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2133.1983.tb03979.x","volume":"108","author":"DM Stoll","year":"1983","unstructured":"Stoll DM, King LE, Chytil F. Serum levels of retinol binding protein in patients with pityriasis rubra pilaris. Br J Dermatol. 1983;108:375.","journal-title":"Br J Dermatol."},{"key":"338_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2133.1982.tb00303.x","volume":"107","author":"A Vahlquist","year":"1982","unstructured":"Vahlquist A. Retinol binding protein and pityriasis rubra pilaris [letter]. Br J Dermatol. 1982;107:125\u20136.","journal-title":"Br J Dermatol"},{"key":"338_CR28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0560.1997.tb00816.x","volume":"24","author":"CM Magro","year":"1997","unstructured":"Magro CM, Crowson AN. The clinical and histomorphological features of pityriasis rubra pilaris. A comparative analysis with psoriasis. J Cutan Pathol. 1997;24:416\u201324.","journal-title":"J Cutan Pathol."},{"key":"338_CR29","first-page":"639","volume":"38","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Yokoyama A. Lymphocyte response to superantigen in a patient with childhood-onset pityriasis rubra pilaris. Int J Dermatol. 1999;38:639\u201340.","journal-title":"Int J Dermatol."},{"key":"338_CR30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1525-1470.2001.01967.x","volume":"18","author":"I Betlloch","year":"2001","unstructured":"Betlloch I, Ram\u00f3n R, Silvestre JF, Carnero L, Albares MP, Ba\u00f1uls J. Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease? Pediatr Dermatol. 2001;18:411\u20134.","journal-title":"Pediatr Dermatol."},{"key":"338_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000240018","volume":"219","author":"S Kawara","year":"2009","unstructured":"Kawara S, Miyake M, Oiso N, Kawada A. Pityriasis rubra pilaris with preceding cytomegalovirus infection. Dermatology. 2009;219:350\u20132.","journal-title":"Dermatology."},{"key":"338_CR32","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3760\/cma.j.issn.0366-6999.20133239","volume":"127","author":"T Wang","year":"2014","unstructured":"Wang T, Liu J, Liu Y, Zheng H. Pityriasis rubra pilaris (PRP) with preceding Epstein-Barr virus infection: a new type PRP with non-HIV virus infection? Chin Med J (Engl). 2014;127:2391.","journal-title":"Chin Med J (Engl)."},{"key":"338_CR33","first-page":"1421","volume":"27","author":"T Erdem","year":"2006","unstructured":"Erdem T, Atasoy M, Aliagaoglu C, Melikoglu M, Yildirim U. Pityriasis rubra pilaris in association with hepatitis A. Saudi Med J. 2006;27:1421\u20132.","journal-title":"Saudi Med J."},{"key":"338_CR34","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1111\/j.1365-2230.2009.03678.x","volume":"34","author":"I Ertam","year":"2009","unstructured":"Ertam I, Sezgin AO, Kazandi A, Dereli T, Unal I. A case of juvenile pityriasis rubra pilaris: could varicella be an aetiological agent? Clin Exp Dermatol. 2009;34:e1012\u20133.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0378-6323.60564","volume":"76","author":"JK Das","year":"2010","unstructured":"Das JK, Gangopadhyay AK, Sengupta S. Pityriasis rubra pilaris with Koebner\u2019s isomorphic phenomenon. Indian J Dermatol Venereol Leprol. 2010;76:194\u20136.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"338_CR36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1067\/mjd.2002.124619","volume":"47","author":"DS Allison","year":"2002","unstructured":"Allison DS, El-Azhary RA, Calobrisi SD, Dicken CH. Pityriasis rubra pilaris in children. J Am Acad Dermatol. 2002;47:386\u20139.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0190-9622(97)80281-2","volume":"36","author":"BD Clayton","year":"1997","unstructured":"Clayton BD, Jorizzo JL, Hitchcock MG, Fleischer AB, Williford PM, Feldman SR, et al. Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol. 1997;36:959\u201364.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaad.2008.07.054","volume":"59","author":"C-C Yang","year":"2008","unstructured":"Yang C-C, Shih I-H, Lin W-L, Yu Y-S, Chiu H-C, Huang P-H, et al. Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan. J Am Acad Dermatol. 2008;59:943\u20138.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5114\/ada.2016.60619","volume":"33","author":"K M\u0119ci\u0144ska-Jundzi\u0142\u0142","year":"2016","unstructured":"M\u0119ci\u0144ska-Jundzi\u0142\u0142 K, Bia\u0142ecka A, Adamska U, Skrzeczko-Kwela E, Czajkowski R. Photosensitive pityriasis rubra pilaris. Postepy Dermatol Alergol. 2016;33:239\u201342.","journal-title":"Postepy Dermatol Alergol."},{"key":"338_CR40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2005.01931.x","volume":"31","author":"HE Iredale","year":"2006","unstructured":"Iredale HE, Meggitt SJ. Photosensitive pityriasis rubra pilaris. Clin Exp Dermatol. 2006;31:36\u20138.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000246871","volume":"189","author":"R Yaniv","year":"1994","unstructured":"Yaniv R, Barzilai A, Trau H. Pityriasis rubra pilaris exacerbated by ultraviolet B phototherapy. Dermatology. 1994;189:313.","journal-title":"Dermatology."},{"key":"338_CR42","first-page":"42","volume":"10","author":"MC Marguery","year":"1994","unstructured":"Marguery MC, Durand-Malgouyres C, Bayle-Lebey P, Dupin P, Bazex J. Photosensitive and phototriggered pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed. 1994;10:42\u20135.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"338_CR43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0781.2005.00179.x","volume":"21","author":"G Evangelou","year":"2005","unstructured":"Evangelou G, Murdoch SR, Palamaras I, Rhodes LE. Photoaggravated pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed. 2005;21:272\u20134.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"338_CR44","first-page":"769","volume":"140","author":"P Kaskel","year":"1999","unstructured":"Kaskel P, Grundmann-Kollmann M, Schiller PI, Kr\u00e4hn G, Pillekamp H, Peter RU, et al. Bath-PUVA as a treatment for Pityriasis rubra pilaris provoked by ultraviolet B. Br J Dermatol. 1999;140:769\u201370.","journal-title":"Br J Dermatol."},{"key":"338_CR45","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jaad.2013.04.061","volume":"69","author":"A Jack","year":"2013","unstructured":"Jack A, Mauro MJ, Ehst BD. Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib. J Am Acad Dermatol. 2013;69:e249\u201350.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2010.03.015","volume":"65","author":"C Paz","year":"2011","unstructured":"Paz C, Querfeld C, Shea CR. Sorafenib-induced eruption resembling pityriasis rubra pilaris. J Am Acad Dermatol. 2011;65:452\u20133.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ced.12081","volume":"38","author":"A Plana","year":"2013","unstructured":"Plana A, Carrascosa JM, Vilavella M, Ferrandiz C. Pityriasis rubra pilaris-like reaction induced by imatinib. Clin Exp Dermatol. 2013;38:520\u20132.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archdermatol.2012.2039","volume":"148","author":"SS Stalling","year":"2012","unstructured":"Stalling SS, Vu JR, English JC. Telaprevir-induced pityriasis rubra pilaris-like drug eruption. Arch Dermatol. 2012;148:1215\u20137.","journal-title":"Arch Dermatol."},{"key":"338_CR49","first-page":"1161","volume":"14","author":"EJ Cheung","year":"2015","unstructured":"Cheung EJ, Jedrych JJ, English JC. Sofosbuvir-induced erythrodermic pityriasis rubra pilaris-like drug eruption. J Drugs Dermatol. 2015;14:1161\u20132.","journal-title":"J Drugs Dermatol."},{"key":"338_CR50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-4632.2008.03729.x","volume":"47","author":"FC Yang","year":"2008","unstructured":"Yang FC, Jessup C, Dahiya M, Reynolds R. Pityriasis rubra pilaris exacerbation with topical use of imiquimod. Int J Dermatol. 2008;47:1076\u20138.","journal-title":"Int J Dermatol."},{"key":"338_CR51","first-page":"412684","volume":"2011","author":"MN Atanaskova","year":"2011","unstructured":"Atanaskova MN, Dawes D, Sood A, Bergfeld W. Acantholytic pityriasis rubra pilaris. Case Rep Dermatol Med. 2011;2011:412684.","journal-title":"Case Rep Dermatol Med"},{"key":"338_CR52","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ad.2010.03.024","volume":"101","author":"E G\u00f3mez-Moyano","year":"2010","unstructured":"G\u00f3mez-Moyano E, Crespo-Erchiga A, Vera Casa\u00f1o A, Sanz Trelles A. Pityriasis rubra pilaris with focal acantholytic dyskeratosis during treatment with imiquimod 5% cream [in Spanish]. Actas Dermosifiliogr. 2010;101:898\u2013900.","journal-title":"Actas Dermosifiliogr"},{"key":"338_CR53","first-page":"E6","volume":"93","author":"A L\u00f3pez-Ferrer","year":"2014","unstructured":"L\u00f3pez-Ferrer A, Dalmau J, Fern\u00e1ndez-Figueras MT, Puig L. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor \u03b1-blocking agents and acitretin. Cutis. 2014;93:E6\u20137.","journal-title":"Cutis."},{"key":"338_CR54","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.1965.01600160080018","volume":"92","author":"DS Waldorf","year":"1965","unstructured":"Waldorf DS, Hambrick GW. Vitamin A\u2014responsive pityriasis rubra pilaris with myasthenia gravis. Arch Dermatol. 1965;92:424\u20137.","journal-title":"Arch Dermatol."},{"key":"338_CR55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1468-3083.2007.02502.x","volume":"22","author":"U G\u00fcl","year":"2008","unstructured":"G\u00fcl U, G\u00f6n\u00fcl M, Kili\u00e7 A, Soylu S, Ko\u00e7ak O, G\u00f6nen B, et al. A case of pityriasis rubra pilaris associated with sacroileitis and autoimmune thyroiditis. J Eur Acad Dermatol Venereol. 2008;22:889\u201390.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"338_CR56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2133.2006.07697.x","volume":"156","author":"V Orlandini","year":"2007","unstructured":"Orlandini V, Cogrel O, Doutre MS, Beylot C, Beylot-Barry M. Pityriasis rubra pilaris and hypothyroidism. Efficacy of thyroid hormone replacement therapy in skin recovery. Br J Dermatol. 2007;156:606\u20137.","journal-title":"Br J Dermatol."},{"key":"338_CR57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/abd1806-4841.20142994","volume":"89","author":"AM Franzotti","year":"2014","unstructured":"Franzotti AM, Avelar JCD, Cardoso TA, Pires MC, Vidigal Mdo R. Pityriasis Rubra Pilar and hypothyroidism. An Bras Dermatol. 2014;89:497\u2013500.","journal-title":"An Bras Dermatol."},{"key":"338_CR58","first-page":"626","volume":"25","author":"HW Randle","year":"1980","unstructured":"Randle HW, Winkelmann RK. Pityriasis rubra pilaris and celiac sprue with malabsorption. Cutis. 1980;25:626\u20137.","journal-title":"Cutis."},{"key":"338_CR59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2230.1988.tb00716.x","volume":"13","author":"AR Hazini","year":"1988","unstructured":"Hazini AR, Rongioletti F, Rebora A. Pityriasis rubra pilaris and vitiligo in Down\u2019s syndrome. Clin Exp Dermatol. 1988;13:334\u20135.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ced.13009","volume":"42","author":"E Bar-Ilan","year":"2017","unstructured":"Bar-Ilan E, Gat A, Sprecher E, Zeeli T. Paraneoplastic pityriasis rubra pilaris: case report and literature review. Clin Exp Dermatol. 2017;42:54\u20137.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000246088","volume":"194","author":"S Sharma","year":"1997","unstructured":"Sharma S, Weiss GR, Paulger B. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Dermatology. 1997;194:166\u20137.","journal-title":"Dermatology."},{"key":"338_CR62","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1111\/j.1365-2230.2009.03701.x","volume":"34","author":"T Batinac","year":"2009","unstructured":"Batinac T, Kujundzi\u0107 M, Peternel S, Cabrijan L, Troselj-Vuki\u0107 B, Petranovi\u0107 D. Pityriasis rubra pilaris in association with laryngeal carcinoma. Clin Exp Dermatol. 2009;34:e917\u20139.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-0960.2004.00061.x","volume":"45","author":"A-M Kurzydlo","year":"2004","unstructured":"Kurzydlo A-M, Gillespie R. Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma. Australas J Dermatol. 2004;45:130\u20132.","journal-title":"Australas J Dermatol."},{"key":"338_CR64","first-page":"610","volume":"13","author":"IM Remedios","year":"2014","unstructured":"Remedios IM, Jensen JD, Beckum K, McKay K, Kissel R. Paraneoplastic pityriasis rubra pilaris as the presenting manifestation of metastatic squamous cell carcinoma. J Drugs Dermatol. 2014;13:610\u20132.","journal-title":"J Drugs Dermatol."},{"key":"338_CR65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D36VR5R017","volume":"17","author":"CB Garretson","year":"2011","unstructured":"Garretson CB, Machan ML, Krejci-Manwaring J, Aires D, Tonkovic-Capin V. Adenocarcinoma of the lung associated with pityriasis rubra pilaris [letter]. Dermatol Online J. 2011;17:14.","journal-title":"Dermatol Online J."},{"key":"338_CR66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2230.2005.01781.x","volume":"30","author":"RJ Batchelor","year":"2005","unstructured":"Batchelor RJ, Yung A, Merchant W, Goodfield MJD. Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? Clin Exp Dermatol. 2005;30:442\u20133.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR67","first-page":"100","volume":"31","author":"LA Reinhardt","year":"1983","unstructured":"Reinhardt LA, Rosen T. Pityriasis rubra pilaris as the initial manifestation of leukemia. Cutis. 1983;31:100\u20132.","journal-title":"Cutis."},{"key":"338_CR68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2230.1995.tb01368.x","volume":"20","author":"M S\u00e1nchez-Rega\u00f1a","year":"1995","unstructured":"S\u00e1nchez-Rega\u00f1a M, L\u00f3pez-Gil F, Salleras M, Umbert P. Pityriasis rubra pilaris as the initial manifestation of internal neoplasia. Clin Exp Dermatol. 1995;20:436\u20138.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR69","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2010.05.013","volume":"68","author":"M Vitiello","year":"2013","unstructured":"Vitiello M, Miteva M, Romanelli P, Castaneda J, Garces-Milanes D, Kirsner R, et al. Pityriasis rubra pilaris: was it the first manifestation of colon cancer in a patient with pre-existing psoriasis? J Am Acad Dermatol. 2013;68:e43\u20134.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2230.1994.tb01141.x","volume":"19","author":"T Piamphongsant","year":"1994","unstructured":"Piamphongsant T, Akaraphant R. Pityriasis rubra pilaris: a new proposed classification. Clin Exp Dermatol. 1994;19:134\u20138.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1440-0960.1960.tb01588.x","volume":"5","author":"J Ingram","year":"1960","unstructured":"Ingram J. Pityriasis rubra pilaris. Aust J Dermatol. 1960;5:177\u201384.","journal-title":"Aust J Dermatol."},{"key":"338_CR72","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1365-4632.2011.04990.x","volume":"50","author":"CJ Ko","year":"2011","unstructured":"Ko CJ, Milstone LM, Choi J, McNiff JM. Pityriasis rubra pilaris: the clinical context of acantholysis and other histologic features. Int J Dermatol. 2011;50:1480\u20135.","journal-title":"Int J Dermatol."},{"key":"338_CR73","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2015.03.050","volume":"73","author":"E Rashidghamat","year":"2015","unstructured":"Rashidghamat E, Griffiths WAD, Mellerio JE, Robson A. Pityriasis rubra pilaris with histologic features of lichen nitidus. J Am Acad Dermatol. 2015;73:336\u20137.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-4632.2012.05811.x","volume":"53","author":"N Marrouche","year":"2014","unstructured":"Marrouche N, Kurban M, Kibbi A-G, Abbas O. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. Int J Dermatol. 2014;53:434\u20139.","journal-title":"Int J Dermatol."},{"key":"338_CR75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/DAD.0000000000000346","volume":"37","author":"E Avitan-Hersh","year":"2015","unstructured":"Avitan-Hersh E, Bergman R. The incidence of acantholysis in pityriasis rubra pilaris-histopathological study using multiple-step sections and clinicopathologic correlations. Am J Dermatopathol. 2015;37:755\u20138.","journal-title":"Am J Dermatopathol."},{"key":"338_CR76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00417199","volume":"275","author":"O Braun-Falco","year":"1983","unstructured":"Braun-Falco O, Ryckmanns F, Schmoeckel C, Landthaler M. Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy. Arch Dermatol Res. 1983;275:287\u201395.","journal-title":"Arch Dermatol Res."},{"key":"338_CR77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10446670410001670008","volume":"11","author":"H Chan","year":"2004","unstructured":"Chan H, Liu FT, Naguwa S. A review of pityriasis rubra pilaris and rheumatologic associations. Clin Dev Immunol. 2004;11:57\u201360.","journal-title":"Clin Dev Immunol."},{"key":"338_CR78","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jaad.2013.01.017","volume":"69","author":"MA Marchetti","year":"2013","unstructured":"Marchetti MA, Greer KE. Pityriasis rubra pilaris treated with methotrexate resolving with an erythema gyratum repens-like appearance. J Am Acad Dermatol. 2013;69:e32\u20133.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2230.2010.03861.x","volume":"36","author":"N Almaani","year":"2011","unstructured":"Almaani N, Robson A, Sarkany R, Griffiths WAD. Erythema gyratum repens associated with pityriasis rubra pilaris. Clin Exp Dermatol. 2011;36:161\u20134.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR80","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archderm.1993.01680280107033","volume":"129","author":"K Gebauer","year":"1993","unstructured":"Gebauer K, Singh G. Resolving pityriasis rubra pilaris resembling erythema gyratum repens. Arch Dermatol. 1993;129:917\u20138.","journal-title":"Arch Dermatol."},{"key":"338_CR81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2230.2006.02344.x","volume":"32","author":"G Caldarola","year":"2007","unstructured":"Caldarola G, Zampetti A, De Simone C, Massi G, Amerio P, Feliciani C. Circumscribed pityriasis rubra pilaris type IV. Clin Exp Dermatol. 2007;32:471\u20132.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-4362.1999.00513.x","volume":"38","author":"MR Albert","year":"1999","unstructured":"Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol. 1999;38:1\u201311.","journal-title":"Int J Dermatol."},{"key":"338_CR83","first-page":"248","volume":"25","author":"W-L Lin","year":"2007","unstructured":"Lin W-L, Lin W-C, Shih I-H, Yang L-C, Hong H-S. Juvenile pityriasis rubra pilaris in Chang Gung Memorial Hospital, Taipei and Linkou: a retrospective study in the past ten years. Dermatol Sin. 2007;25:248\u201355.","journal-title":"Dermatol Sin."},{"key":"338_CR84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1525-1470.2007.00603.x","volume":"25","author":"D Karimian-Teherani","year":"2008","unstructured":"Karimian-Teherani D, Parissa M, Tanew A. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Pediatr Dermatol. 2008;25:125\u20136.","journal-title":"Pediatr Dermatol."},{"key":"338_CR85","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1994.tb13121.x","volume":"130","author":"PC Kerkhof Van de","year":"1994","unstructured":"Van de Kerkhof PC, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol. 1994;130:675\u20138.","journal-title":"Br J Dermatol."},{"key":"338_CR86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/09546639709160521","volume":"8","author":"L Jaimovich","year":"1997","unstructured":"Jaimovich L, Mordoh A, Schroh R. Treatment of circumscribed juvenile type of pityriasis rubra pilaris with calcipotriol. J Dermatol Treat. 1997;8:211\u20132.","journal-title":"J Dermatol Treat."},{"key":"338_CR87","first-page":"340","volume":"6","author":"S Gregoriou","year":"2007","unstructured":"Gregoriou S, Argyriou G, Christofidou E, Vranou A, Rigopoulos D. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%. J Drugs Dermatol. 2007;6:340\u20132.","journal-title":"J Drugs Dermatol."},{"key":"338_CR88","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0190-9622(82)70061-1","volume":"6","author":"LA Goldsmith","year":"1982","unstructured":"Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol. 1982;6:710\u20135.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR89","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0190-9622(90)70110-4","volume":"22","author":"M Borok","year":"1990","unstructured":"Borok M, Lowe NJ. Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. J Am Acad Dermatol. 1990;22:792\u20135.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR90","first-page":"593","volume":"4","author":"M Sanchez-Regana","year":"1994","unstructured":"Sanchez-Regana M, Creus L, Umbert P. Pityriasis rubra pilaris. A long-term study of 25 cases. Eur J Dermatol. 1994;4:593\u20137.","journal-title":"Eur J Dermatol."},{"key":"338_CR91","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0190-9622(94)70271-3","volume":"31","author":"CH Dicken","year":"1994","unstructured":"Dicken CH. Treatment of classic pityriasis rubra pilaris. J Am Acad Dermatol. 1994;31:997\u20139.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR92","first-page":"439","volume":"8","author":"A Gemmeke","year":"2010","unstructured":"Gemmeke A, Sch\u00f6nlebe J, Koch A, Wollina U. Pityriasis rubra pilaris\u2013a retrospective single center analysis over eight years [in English, German]. J Dtsch Dermatol Ges. 2010;8:439\u201344.","journal-title":"J Dtsch Dermatol Ges"},{"key":"338_CR93","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamadermatol.2013.4773","volume":"150","author":"AB Eastham","year":"2014","unstructured":"Eastham AB, Femia AN, Qureshi A, Vleugels RA. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol. 2014;150:92\u20134.","journal-title":"JAMA Dermatol."},{"key":"338_CR94","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5021\/ad.2016.28.3.388","volume":"28","author":"HS Lee","year":"2016","unstructured":"Lee HS, Lee E-S. Classic juvenile pityriasis rubra pilaris treated with oral alitretinoin. Ann Dermatol. 2016;28:388\u201390.","journal-title":"Ann Dermatol."},{"key":"338_CR95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/dth.12320","volume":"29","author":"CH Yun","year":"2016","unstructured":"Yun CH, Kim JS, Ryu HR, Kim JH, Baek JO, Lee JR, et al. Circumscribed juvenile pityriasis rubra pilaris responsive to alitretinoin. Dermatol Ther. 2016;29:81\u20133.","journal-title":"Dermatol Ther."},{"key":"338_CR96","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.jaad.2013.01.036","volume":"69","author":"A Pamp\u00edn","year":"2013","unstructured":"Pamp\u00edn A, G\u00f3mez-de la Fuente E, Caro Guti\u00e9rrez MD, L\u00f3pez-Estebaranz JL. Successful treatment of atypical adult pityriasis rubra pilaris with oral alitretinoin. J Am Acad Dermatol. 2013;69:e105\u20136.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000327704","volume":"3","author":"L Schmitt","year":"2011","unstructured":"Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris. Case Rep Dermatol. 2011;3:85\u20138.","journal-title":"Case Rep Dermatol."},{"key":"338_CR98","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.2010.09782.x","volume":"163","author":"S Molin","year":"2010","unstructured":"Molin S, Ruzicka T. Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol. 2010;163:221\u20133.","journal-title":"Br J Dermatol."},{"key":"338_CR99","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2340\/00015555-1928","volume":"95","author":"PM Amann","year":"2015","unstructured":"Amann PM, Susic M, Gl\u00fcder F, Berger H, Krapf W, L\u00f6ffler H. Alitretinoin (9-cis retinoic acid) is effective against pityriasis rubra pilaris: a retrospective clinical study. Acta Derm Venereol. 2015;95:329\u201331.","journal-title":"Acta Derm Venereol."},{"key":"338_CR100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/S0190-9622(03)01564-0","volume":"49","author":"AR Brecher","year":"2003","unstructured":"Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49:171\u201382 (quiz 183\u2013186).","journal-title":"J Am Acad Dermatol."},{"key":"338_CR101","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1\u201337.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR102","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","volume":"162","author":"AD Ormerod","year":"2010","unstructured":"Ormerod AD, Campalani E, Goodfield MJ, BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952\u201363.","journal-title":"Br J Dermatol."},{"key":"338_CR103","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09546639909056012","volume":"10","author":"V Chapalain","year":"1999","unstructured":"Chapalain V, Beylot-Barry M, Doutre MS, Beylot C. Treatment of pityriasis rubra pilaris: a retrospective study of 14 patients. J Dermatol Treat. 1999;10:113\u20137.","journal-title":"J Dermatol Treat."},{"key":"338_CR104","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0190-9622(95)90396-8","volume":"32","author":"RJ Dooren-Greebe van","year":"1995","unstructured":"van Dooren-Greebe RJ, van de Kerkhof PC. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J Am Acad Dermatol. 1995;32:322\u20135.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000249755","volume":"167","author":"HI Beck","year":"1983","unstructured":"Beck HI, Foged EK. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis. Dermatologica. 1983;167:94\u20136.","journal-title":"Dermatologica."},{"key":"338_CR106","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(88)91223-8","volume":"1","author":"H Zachariae","year":"1988","unstructured":"Zachariae H. Dangers of methotrexate\/etretinate combination therapy [letter]. Lancet. 1988;1:422.","journal-title":"Lancet."},{"key":"338_CR107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2230.1991.tb00341.x","volume":"16","author":"JT Lim","year":"1991","unstructured":"Lim JT, Tham SN. Pityriasis rubra pilaris in Singapore. Clin Exp Dermatol. 1991;16:181\u20134.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR108","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0190-9622(99)70029-0","volume":"41","author":"L Khoo","year":"1999","unstructured":"Khoo L, Asawanonda P, Grevelink SA, Taylor CR. Narrow-band UVB-associated lesional blisters in pityriasis rubra pilaris. J Am Acad Dermatol. 1999;41:803\u20134.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR109","first-page":"271","volume":"143","author":"P Betto","year":"2008","unstructured":"Betto P, Vassilopoulou A, Colombari R, Veller-Fornasa C. Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection. G Ital Dermatol Venereol. 2008;143:271\u20133.","journal-title":"G Ital Dermatol Venereol."},{"key":"338_CR110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/0378-6323.156196","volume":"81","author":"AF Massa","year":"2015","unstructured":"Massa AF, Vasconcelos P, Soares de Almeida L, Filipe P. Pityriasis rubra pilaris mixed type III\/IV successfully treated with narrow band-ultraviolet B. Indian J Dermatol Venereol Leprol. 2015;81:435.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"338_CR111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2133.2000.03388.x","volume":"142","author":"RA Herbst","year":"2000","unstructured":"Herbst RA, Vogelbruch M, Ehnis A, Kiehl P, Kapp A, Weiss J. Combined ultraviolet al radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br J Dermatol. 2000;142:574\u20135.","journal-title":"Br J Dermatol."},{"key":"338_CR112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2230.2000.00616.x","volume":"25","author":"CM Neess","year":"2000","unstructured":"Neess CM, Hinrichs R, Dissemond J, Herrmann G, Poswig A, Servera-Llanras M, et al. Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy. Clin Exp Dermatol. 2000;25:209\u201311.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2133.2000.03316.x","volume":"142","author":"B Kirby","year":"2000","unstructured":"Kirby B, Watson R. Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01). Br J Dermatol. 2000;142:376\u20137.","journal-title":"Br J Dermatol."},{"key":"338_CR114","first-page":"9","volume":"11","author":"AV Booth","year":"2005","unstructured":"Booth AV, Ma L. Pityriasis rubra pilaris, type 1. Dermatol Online J. 2005;11:9.","journal-title":"Dermatol Online J."},{"key":"338_CR115","first-page":"270","volume":"8","author":"IJ Vergilis-Kalner","year":"2009","unstructured":"Vergilis-Kalner IJ, Mann DJ, Wasserman J, Petronic-Rosic V, Tsoukas MM. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy. J Drugs Dermatol. 2009;8:270\u20133.","journal-title":"J Drugs Dermatol."},{"key":"338_CR116","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.jaad.2008.06.016","volume":"59","author":"V Cox","year":"2008","unstructured":"Cox V, Lesesky EB, Garcia BD, O\u2019Grady TC. Treatment of juvenile pityriasis rubra pilaris with etanercept. J Am Acad Dermatol. 2008;59:S113\u20134.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archdermatol.2008.527","volume":"145","author":"HW Walling","year":"2009","unstructured":"Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol. 2009;145:99\u2013101.","journal-title":"Arch Dermatol."},{"key":"338_CR118","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000337546","volume":"224","author":"K Ivanova","year":"2012","unstructured":"Ivanova K, Itin P, Haeusermann P. Pityriasis rubra pilaris: treatment with biologics\u2014a new promising therapy? Dermatology. 2012;224:120\u20135.","journal-title":"Dermatology."},{"key":"338_CR119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000346640","volume":"226","author":"L Adnot-Desanlis","year":"2013","unstructured":"Adnot-Desanlis L, Antonicelli F, Tabary T, Bernard P, Reguia\u00ef Z. Effectiveness of infliximab in pityriasis rubra pilaris is associated with pro-inflammatory cytokine inhibition. Dermatology. 2013;226:41\u20136.","journal-title":"Dermatology."},{"key":"338_CR120","first-page":"630","volume":"20","author":"R Ruiz Villaverde","year":"2010","unstructured":"Ruiz Villaverde R, S\u00e1nchez Cano D. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy. Eur J Dermatol. 2010;20:630\u20131.","journal-title":"Eur J Dermatol."},{"key":"338_CR121","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2008.05.037","volume":"59","author":"H M\u00fcller","year":"2008","unstructured":"M\u00fcller H, Gattringer C, Zelger B, H\u00f6pfl R, Eisendle K. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol. 2008;59:S65\u201370.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR122","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1111\/j.1468-3083.2012.04456.x","volume":"27","author":"G Petrof","year":"2013","unstructured":"Petrof G, Almaani N, Archer CB, Griffiths WA, Smith CH. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol. 2013;27:e131\u20135.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"338_CR123","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0378-6323.157457","volume":"82","author":"AS Karadag","year":"2016","unstructured":"Karadag AS, Kavala M, Ozlu E, Ozkanl\u0131 S, Zindanc\u0131 \u0130, Turkoglu Z. Erythrodermic pityriasis rubra pilaris: dramatic response to infliximab therapy. Indian J Dermatol Venereol Leprol. 2016;82:112.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"338_CR124","first-page":"217","volume":"12","author":"AR Mattox","year":"2013","unstructured":"Mattox AR, Chappell JA, Hurley MY. New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris. J Drugs Dermatol. 2013;12:217\u20139.","journal-title":"J Drugs Dermatol."},{"key":"338_CR125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/120347540300700503","volume":"7","author":"A Drosou","year":"2003","unstructured":"Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg. 2003;7:382\u20136.","journal-title":"J Cutan Med Surg."},{"key":"338_CR126","first-page":"1071","volume":"7","author":"D Barth","year":"2009","unstructured":"Barth D, Harth W, Treudler R, Simon JC. Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate. J Dtsch Dermatol Ges. 2009;7:1071\u20134.","journal-title":"J Dtsch Dermatol Ges."},{"key":"338_CR127","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/archderm.141.4.423","volume":"141","author":"WC Liao","year":"2005","unstructured":"Liao WC, Mutasim DF. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol. 2005;141:423\u20135.","journal-title":"Arch Dermatol."},{"key":"338_CR128","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1440-0960.2006.00247.x","volume":"47","author":"S Manoharan","year":"2006","unstructured":"Manoharan S, White S, Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol. 2006;47:124\u20139.","journal-title":"Australas J Dermatol."},{"key":"338_CR129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2340\/00015555-0308","volume":"87","author":"DP Ruiz-Genao","year":"2007","unstructured":"Ruiz-Genao DP, Lopez-Estebaranz JL, Naz-Villalba E, Gamo-Villegas R, Calzado-Villarreal L, Pinedo-Moraleda F. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol. 2007;87:552\u20133.","journal-title":"Acta Derm Venereol."},{"key":"338_CR130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2230.2011.04074.x","volume":"36","author":"M Zirbs","year":"2011","unstructured":"Zirbs M, Kigitsidou E, Seifert F, Ring J, Brockow K. Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid. Clin Exp Dermatol. 2011;36:808\u20139.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR131","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1684\/ejd.2011.1325","volume":"21","author":"C Dessinioti","year":"2011","unstructured":"Dessinioti C, Vergou T, Moustou E, Katsambas A, Antoniou C. Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris. Eur J Dermatol. 2011;21:599\u2013600.","journal-title":"Eur J Dermatol."},{"key":"338_CR132","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1468-3083.2009.03511.x","volume":"24","author":"S Garcovich","year":"2010","unstructured":"Garcovich S, Di Giampetruzzi AR, Antonelli G, Garcovich A, Didona B. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series. J Eur Acad Dermatol Venereol. 2010;24:881\u20134.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"338_CR133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-3083.2007.02282.x","volume":"22","author":"M Ruzzetti","year":"2008","unstructured":"Ruzzetti M, Saraceno R, Carboni I, Papoutsaki M, Chimenti S. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. J Eur Acad Dermatol Venereol. 2008;22:117\u20138.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"338_CR134","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1684\/ejd.2013.2175","volume":"23","author":"I Vujic","year":"2013","unstructured":"Vujic I, Richter L, Bartsch K, Monshi B, Rappersberger K. Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists. Eur J Dermatol. 2013;23:895\u20136.","journal-title":"Eur J Dermatol."},{"key":"338_CR135","first-page":"18","volume":"12","author":"R Lu","year":"2006","unstructured":"Lu R, George SJ, Hsu S. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab. Dermatol Online J. 2006;12:18.","journal-title":"Dermatol Online J."},{"key":"338_CR136","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1111\/dth.12443","volume":"30","author":"A Salman","year":"2017","unstructured":"Salman A, Sonmez Y, Sahin H, Unal AU, Direskeneli H, Cinel L, et al. Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu\u2019s arteritis. Dermatol Ther. 2017;30:e12443.","journal-title":"Dermatol Ther."},{"key":"338_CR137","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2340\/00015555-1367","volume":"92","author":"JH Kim","year":"2012","unstructured":"Kim JH, Park M-C, Kim S-C. Etanercept-induced clinical remission of type II pityriasis rubra pilaris with rheumatoid arthritis. Acta Derm Venereol. 2012;92:399\u2013400.","journal-title":"Acta Derm Venereol."},{"key":"338_CR138","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1529-8019.2011.01404.x","volume":"24","author":"R Guedes","year":"2011","unstructured":"Guedes R, Leite L. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept. Dermatol Ther. 2011;24:285\u20136.","journal-title":"Dermatol Ther."},{"key":"338_CR139","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2007.08379.x","volume":"158","author":"D Seckin","year":"2008","unstructured":"Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol. 2008;158:642\u20134.","journal-title":"Br J Dermatol."},{"key":"338_CR140","first-page":"1597","volume":"143","author":"KF Davis","year":"2007","unstructured":"Davis KF, Wu JJ, Murase JE, Rosenberg FR, Sorenson EP, Meshkinpour A. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol. 2007;143:1597\u20139.","journal-title":"Arch Dermatol."},{"key":"338_CR141","first-page":"337","volume":"6","author":"M G\u00f3mez","year":"2007","unstructured":"G\u00f3mez M, Ruelas MEH, Welsh O, Arcaute HD, Ocampo-Candiani J. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. J Drugs Dermatol. 2007;6:337\u20139.","journal-title":"J Drugs Dermatol."},{"key":"338_CR142","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2310\/7750.2010.09023","volume":"14","author":"Y-H Zhang","year":"2010","unstructured":"Zhang Y-H, Zhou Y, Ball N, Su M-W, Xu J-H, Zheng Z-Z. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy. J Cutan Med Surg. 2010;14:185\u20138.","journal-title":"J Cutan Med Surg."},{"key":"338_CR143","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2230.2010.03806.x","volume":"35","author":"S Schreml","year":"2010","unstructured":"Schreml S, Zeller V, Babilas P, Karrer S, Landthaler M, Szeimies R-M. Pityriasis rubra pilaris successfully treated with adalimumab. Clin Exp Dermatol. 2010;35:792\u20133.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR144","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/j.1365-2230.2009.03747.x","volume":"35","author":"D O\u2019Kane","year":"2010","unstructured":"O\u2019Kane D, Devereux CE, Walsh MY, Hoey SEH. Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment. Clin Exp Dermatol. 2010;35:e155\u20136.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2012.09.018","volume":"68","author":"H-Y Chiu","year":"2013","unstructured":"Chiu H-Y, Tsai T-F. Pityriasis rubra pilaris with polyarthritis treated with adalimumab. J Am Acad Dermatol. 2013;68:187\u20138.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR146","first-page":"244","volume":"90","author":"C Wassef","year":"2012","unstructured":"Wassef C, Lombardi A, Rao BK. Adalimumab for the treatment of pityriasis rubra pilaris: a case report. Cutis. 2012;90:244\u20137.","journal-title":"Cutis."},{"key":"338_CR147","doi-asserted-by":"crossref","first-page":"22374","DOI":"10.5070\/D3204022374","volume":"20","author":"EA Bravo","year":"2014","unstructured":"Bravo EA, Carrion L, Paucar SM, Mendoza R, Rivera C. Successful treatment of pityriasis rubra pilaris with adalimumab\u2014case report. Dermatol Online J. 2014;20:22374.","journal-title":"Dermatol Online J."},{"key":"338_CR148","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/1346-8138.13038","volume":"42","author":"BR Kim","year":"2015","unstructured":"Kim BR, Chae JB, Park JT, Byun SY, Youn SW. Clinical remission of pityriasis rubra pilaris with adalimumab in an adolescent patient. J Dermatol. 2015;42:1122\u20133.","journal-title":"J Dermatol."},{"key":"338_CR149","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1346-8138.13478","volume":"44","author":"N Kitayama","year":"2017","unstructured":"Kitayama N, Nakamizo S, Kaku Y, Endo Y, Fujisawa A, Otsuka A, et al. Case of pityriasis rubra pilaris with annular pattern as an early manifestation. J Dermatol. 2017;44:478\u20139.","journal-title":"J Dermatol."},{"key":"338_CR150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4110\/in.2014.14.1.14","volume":"14","author":"S-H Park","year":"2014","unstructured":"Park S-H, Cho G, Park S-G. NF-\u03baB activation in T helper 17 cell differentiation. Immune Netw. 2014;14:14\u201320.","journal-title":"Immune Netw."},{"key":"338_CR151","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","volume":"153","author":"L Feldmeyer","year":"2017","unstructured":"Feldmeyer L, Mylonas A, Demaria O, Mennella A, Yawalkar N, Laffitte E, et al. Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris. JAMA Dermatol. 2017;153:304\u20138.","journal-title":"JAMA Dermatol."},{"key":"338_CR152","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/2229-5178.156410","volume":"6","author":"VD Lernia","year":"2015","unstructured":"Lernia VD, Ficarelli E, Zanelli M. Ineffectiveness of tumor necrosis factor-\u03b1 blockers and ustekinumab in a case of type IV pityriasis rubra pilaris. Indian Dermatol Online J. 2015;6:207\u20139.","journal-title":"Indian Dermatol Online J."},{"key":"338_CR153","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15462","author":"SM Lwin","year":"2017","unstructured":"Lwin SM, Hsu C-K, Liu L, Huang H-Y, Levell NJ, McGrath JA. Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14. Br J Dermatol. 2017. https:\/\/doi.org\/10.1111\/bjd.15462 (Epub 2017 Mar 16).","journal-title":"Br J Dermatol"},{"key":"338_CR154","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bjd.12952","volume":"171","author":"O Eytan","year":"2014","unstructured":"Eytan O, Sarig O, Sprecher E, van Steensel MA. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14. Br J Dermatol. 2014;171:420\u20132.","journal-title":"Br J Dermatol."},{"key":"338_CR155","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1111\/jdv.14009","volume":"31","author":"A Paganelli","year":"2017","unstructured":"Paganelli A, Ciardo S, Odorici G, Pellacani G, Conti A. Efficacy of ustekinumab after failure of infliximab CT-P13 in a HLA-Cw6-positive patient affected by pityriasis rubra pilaris: monitoring with reflectance confocal microscopy (RCM) and optical coherence tomography (OCT). J Eur Acad Dermatol Venereol. 2017;31:e249\u201351.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"338_CR156","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/1346-8138.12927","volume":"42","author":"Y Byekova","year":"2015","unstructured":"Byekova Y, Sami N. Successful response of refractory type I adult-onset pityriasis rubra pilaris with ustekinumab and acitretin combination therapy. J Dermatol. 2015;42:830\u20131.","journal-title":"J Dermatol."},{"key":"338_CR157","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000381011","volume":"7","author":"M Chowdhary","year":"2015","unstructured":"Chowdhary M, Davila U, Cohen DJ. Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris. Case Rep Dermatol. 2015;7:46\u201350.","journal-title":"Case Rep Dermatol."},{"key":"338_CR158","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3315\/jdcr.2013.1127","volume":"7","author":"A Stefani Di","year":"2013","unstructured":"Di Stefani A, Galluzzo M, Talamonti M, Chiricozzi A, Costanzo A, Chimenti S. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. J Dermatol Case Rep. 2013;7:5\u20139.","journal-title":"J Dermatol Case Rep."},{"key":"338_CR159","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2133.2010.09855.x","volume":"163","author":"J Wohlrab","year":"2010","unstructured":"Wohlrab J, Kreft B. Treatment of pityriasis rubra pilaris with ustekinumab. Br J Dermatol. 2010;163:655\u20136.","journal-title":"Br J Dermatol."},{"key":"338_CR160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bjd.12331","volume":"169","author":"M Talamonti","year":"2013","unstructured":"Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, et al. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B\/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12\/23 blocker ustekinumab. Br J Dermatol. 2013;169:458\u201363.","journal-title":"Br J Dermatol."},{"key":"338_CR161","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2016.3885","volume":"152","author":"D Schuster","year":"2016","unstructured":"Schuster D, Pfister-Wartha A, Bruckner-Tuderman L, Schempp CM. Successful treatment of refractory pityriasis rubra pilaris with secukinumab. JAMA Dermatol. 2016;152:1278\u201380.","journal-title":"JAMA Dermatol."},{"key":"338_CR162","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jdcr.2016.09.006","volume":"2","author":"M-L Gauci","year":"2016","unstructured":"Gauci M-L, Jachiet M, Gottlieb J, Madeleine-Chambrin I, Rybojad M, Bagot M, et al. Successful treatment of type II pityriasis rubra pilaris with secukinumab. JAAD Case Rep. 2016;2:462\u20134.","journal-title":"JAAD Case Rep."},{"key":"338_CR163","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1972.tb05096.x","volume":"87","author":"GA Hunter","year":"1972","unstructured":"Hunter GA, Forbes IJ. Treatment of pityriasis rubra pilaris with azathioprine. Br J Dermatol. 1972;87:42\u20135.","journal-title":"Br J Dermatol."},{"key":"338_CR164","first-page":"54","volume":"50","author":"CL Anand","year":"1984","unstructured":"Anand CL, Rathore SB. Therapeutic efficacy of azathioprine in pityriasis rubra pilaris. Indian J Dermatol Venereol Leprol. 1984;50:54.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"338_CR165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000018397","volume":"200","author":"K Usuki","year":"2000","unstructured":"Usuki K, Sekiyama M, Shimada T, Shimada S, Kanzaki T. Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A. Dermatology. 2000;200:324\u20137.","journal-title":"Dermatology."},{"key":"338_CR166","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2133.2003.05394.x","volume":"149","author":"T Wetzig","year":"2003","unstructured":"Wetzig T, Sticherling M. Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin. Br J Dermatol. 2003;149:202\u20133.","journal-title":"Br J Dermatol."},{"key":"338_CR167","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamadermatol.2015.3405","volume":"152","author":"IZ Krase","year":"2016","unstructured":"Krase IZ, Cavanaugh K, Curiel-Lewandrowski C. Treatment of refractory pityriasis rubra pilaris with novel phosphodiesterase 4 (PDE4) inhibitor apremilast. JAMA Dermatol. 2016;152:348\u201350.","journal-title":"JAMA Dermatol."},{"key":"338_CR168","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2133.2007.07773.x","volume":"156","author":"AC Kerr","year":"2007","unstructured":"Kerr AC, Ferguson J. Type II adult-onset pityriasis rubra pilaris successfully treated with intravenous immunoglobulin. Br J Dermatol. 2007;156:1055\u20136.","journal-title":"Br J Dermatol."},{"key":"338_CR169","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1610-0387.2009.07290_supp.x","volume":"8","author":"L Popova","year":"2010","unstructured":"Popova L, Darlenski R, Tsankov N. Penicillin and vitamin A as possible therapeutic agents in pityriasis rubra pilaris. J Dtsch Dermatol Ges. 2010;8:354\u20136.","journal-title":"J Dtsch Dermatol Ges."},{"key":"338_CR170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1684\/ejd.2010.1166","volume":"21","author":"S-Y Ahn","year":"2011","unstructured":"Ahn S-Y, Kim J-H, Ahn SK, Oh YS. Clinical improvement of pityriasis rubra pilaris with antibiotic therapy. Eur J Dermatol. 2011;21:106\u20137.","journal-title":"Eur J Dermatol."},{"key":"338_CR171","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2133.2005.06356.x","volume":"152","author":"B Coras","year":"2005","unstructured":"Coras B, Vogt TH, Ulrich H, Landthaler M, Hohenleutner U. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br J Dermatol. 2005;152:388\u20139.","journal-title":"Br J Dermatol."},{"key":"338_CR172","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2230.2004.01468.x","volume":"29","author":"HA Haenssle","year":"2004","unstructured":"Haenssle HA, Bertsch HP, Emmert S, Wolf C, Zutt M. Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris. Clin Exp Dermatol. 2004;29:244\u20136.","journal-title":"Clin Exp Dermatol."},{"key":"338_CR173","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.135.4.475","volume":"135","author":"A Hofer","year":"1999","unstructured":"Hofer A, M\u00fcllegger R, Kerl H, Wolf P. Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris. Arch Dermatol. 1999;135:475\u20136.","journal-title":"Arch Dermatol."},{"key":"338_CR174","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0190-9622(08)80734-7","volume":"27","author":"N Auffret","year":"1992","unstructured":"Auffret N, Quint L, Domart P, Dubertret L, Lecam JY, Binet O. Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27:260\u20131.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0190-9622(91)70106-C","volume":"24","author":"A Blauvelt","year":"1991","unstructured":"Blauvelt A, Nahass GT, Pardo RJ, Kerdel FA. Pityriasis rubra pilaris and HIV infection. J Am Acad Dermatol. 1991;24:703\u20135.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR176","first-page":"118","volume":"314","author":"RA Bonomo","year":"1997","unstructured":"Bonomo RA, Korman N, Nagashima-Whalen L, Briggs J, Graham R, Salata RA. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS. Am J Med Sci. 1997;314:118\u201321.","journal-title":"Am J Med Sci."},{"key":"338_CR177","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1540-9740.2007.07167.x","volume":"7","author":"D De","year":"2008","unstructured":"De D, Dogra S, Narang T, Radotra BD, Kanwar AJ. Pityriasis rubra pilaris in a HIV-positive patient (Type 6 PRP). Skinmed. 2008;7:47\u201350.","journal-title":"Skinmed."},{"key":"338_CR178","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2325957415614649","volume":"15","author":"L Lerebours-Nadal","year":"2016","unstructured":"Lerebours-Nadal L, Beck-Sague CM, Parker D, Gosman A, Saavedra A, Engel K, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11\u20134.","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"338_CR179","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000372-199308000-00013","volume":"15","author":"C Perrin","year":"1993","unstructured":"Perrin C, Durant JM, Lacour JP, Michiels JF, Dellamonica P, Ortonne JP. Horny perifollicular mucinosis. An atypical pityriasis rubra pilaris-like eruption associated with HIV infection. Am J Dermatopathol. 1993;15:358\u201362.","journal-title":"Am J Dermatopathol."},{"key":"338_CR180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(08)81854-3","volume":"29","author":"SD Resnick","year":"1993","unstructured":"Resnick SD, Murrell DF, Woosley JT. Pityriasis rubra pilaris, acne conglobata, and elongated follicular spines: an HIV-associated follicular syndrome? J Am Acad Dermatol. 1993;29:283.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR181","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0190-9622(08)80267-8","volume":"27","author":"S Menni","year":"1992","unstructured":"Menni S, Brancaleone W, Grimalt R. Pityriasis rubra pilaris in a child seropositive for the human immunodeficiency virus. J Am Acad Dermatol. 1992;27:1009.","journal-title":"J Am Acad Dermatol."},{"key":"338_CR182","unstructured":"OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford: Oxford Centre for Evidence-Based Medicine. http:\/\/www.cebm.net\/index.aspx?o=5653. Accessed 15 Dec 2017."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T08:23:34Z","timestamp":1719735814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":182,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0338-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]}}}